Preclinical Safety Studies: An INSC and Charles River Laboratories Training Webinar
Hosted by INSC
This event has concluded — recordings now available.
Experts from Charles River Laboratories—Pragati Coder, JoAnna Bultman, and Bevin Zimmerman—provided an overview of preclinical safety study designs, including two foundational OECD guidelines: the 90-day repeated dose oral toxicity study (OECD 408) and the extended one-generation reproductive toxicity study (OECD 443). These studies are commonly used to establish ingredient safety across the pharmaceutical, agrochemical, and food industries. The session covered study design, key safety endpoints, and how data from these studies inform regulatory decision-making.
